New Results
Hypoxia-directed tumor targeting of CRISPR/Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles
View ORCID ProfileAlicia Davis, View ORCID ProfileKevin V. Morris, View ORCID ProfileGalina Shevchenko
doi: https://doi.org/10.1101/2021.09.30.462477
Alicia Davis
1Center for Gene Therapy, Beckman Research Institute, City of Hope, Duarte, CA, USA
2Irell & Manella Graduate School of Biological Sciences, City of Hope, Duarte, CA, USA
Kevin V. Morris
1Center for Gene Therapy, Beckman Research Institute, City of Hope, Duarte, CA, USA
3Menzies Health Institute Queensland, School of Medical Science Griffith University, Gold Coast Campus, QLD 4222, Australia
Galina Shevchenko
1Center for Gene Therapy, Beckman Research Institute, City of Hope, Duarte, CA, USA
2Irell & Manella Graduate School of Biological Sciences, City of Hope, Duarte, CA, USA
Posted September 30, 2021.
Hypoxia-directed tumor targeting of CRISPR/Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles
Alicia Davis, Kevin V. Morris, Galina Shevchenko
bioRxiv 2021.09.30.462477; doi: https://doi.org/10.1101/2021.09.30.462477
Subject Area
Subject Areas
- Biochemistry (11718)
- Bioengineering (8724)
- Bioinformatics (29132)
- Biophysics (14936)
- Cancer Biology (12051)
- Cell Biology (17360)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14146)
- Epidemiology (2067)
- Evolutionary Biology (18269)
- Genetics (12223)
- Genomics (16768)
- Immunology (11844)
- Microbiology (28016)
- Molecular Biology (11560)
- Neuroscience (60822)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10401)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)